Knockdown of LncRNA CCAT1 Attenuates ox‐LDL‐Induced Inflammation in THP1‐Derived Macrophages via the miR‐296‐3p/FOSL1 Axis
Cardiovascular Therapeutics · 2025
DOI: 10.1155/cdr/9277233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Haiping Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kunming Tongren Hospital, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, MicroRNAs, Lipoproteins, LDL, Macrophages. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Macrophage‐driven inflammation, induced by dysfunctional lipid metabolism, is a pivotal process in the pathogenesis of atherosclerosis (AS). While long noncoding RNAs (LncRNAs) are established regulators, the specific mechanisms governing their roles remain largely uncharacterized. Here, we demonstrate that the LncRNA colon cancer–associated transcript 1 (CCAT1) is significantly upregulated in THP1‐derived macrophages upon stimulation with oxidized low‐density lipoprotein (ox‐LDL). Silencing LncRNA CCAT1 markedly attenuated the ox‐LDL‐induced inflammatory response, establishing its proinflammatory function. Mechanistically, we identified miR‐296‐3p as a direct downstream target of LncRNA CCAT1, which acts as a molecular sponge. This interaction was validated by dual‐luciferase and RNA pull‐down assays. Furthermore, we show that miR‐296‐3p suppresses inflammation by directly targeting the mRNA of FOS‐like antigen 1 (FOSL1). Crucially, overexpression of LncRNA CCAT1 increased FOSL1 levels, confirming this regulatory axis. Collectively, our findings delineate a novel pro‐inflammatory pathway where LncRNA CCAT1 promotes macrophage inflammation by sponging miR‐296‐3p, thereby derepressing its target FOSL1. Therefore, targeting LncRNA CCAT1 represents a promising therapeutic strategy for treating atherosclerotic cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Kunming Tongren Hospital, Kunming, Yunnan, China.
- Department of Cardiology, Jintang County First People's Hospital, Chengdu, Sichuan, China.
- Department of General Practice, Xinqiao Hospital, Chongqing, China, xqhospital.com.cn.
ORCID-Profile: Binfeng He, Jinshan Ye
Zitieren
APA
Zhang, H., Liu, F., Miao, G., Wang, Y., Zhang, L., Yang, C., Huang, K., Guo, F., An, J., He, B., & Ye, J. (2025). Knockdown of LncRNA CCAT1 Attenuates ox‐LDL‐Induced Inflammation in THP1‐Derived Macrophages via the miR‐296‐3p/FOSL1 Axis. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/9277233
Vancouver
Zhang H, Liu F, Miao G, Wang Y, Zhang L, Yang C, et al. Knockdown of LncRNA CCAT1 Attenuates ox‐LDL‐Induced Inflammation in THP1‐Derived Macrophages via the miR‐296‐3p/FOSL1 Axis. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/9277233
BibTeX
@article{Zhang2025,
author = {Zhang, Haiping and Liu, Feng and Miao, Guihua and Wang, Yijiao and Zhang, Lijun and Yang, Chun and Huang, Kai and Guo, Fengyun and An, JunBo and He, Binfeng and Ye, Jinshan},
title = {Knockdown of LncRNA CCAT1 Attenuates ox‐LDL‐Induced Inflammation in THP1‐Derived Macrophages via the miR‐296‐3p/FOSL1 Axis},
journal = {Cardiovascular Therapeutics},
year = {2025},
doi = {10.1155/cdr/9277233}
}
EUVIMED